Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Chatenoud

Showing results (41-50 of 259) with videos related to

Pageof 26
Sort By:
Experimental Nephrology|March 1, 1993
In vivo T cell activation properties of anti-T cell monoclonal antibodiesC Ferran, J F Bach, L Chatenoud
Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine|April 1, 1993
[Monoclonal antibodies. Diagnostic and therapeutic use and prospects for the future]C Ferran, J F Bach, L Chatenoud
Kidney International. Supplement|January 1, 1994
Immunological considerations of the uremic and dialyzed patientL Chatenoud, P Jungers, B Descamps-Latscha
Presse Medicale (Paris, France : 1983)|March 24, 1984
[Role of interleukins in autoimmunity]D Fradelizi, A Harel-Bellan, L Chatenoud
Current Topics in Microbiology and Immunology|January 1, 1991
The anti-CD3-induced syndrome: a consequence of massive in vivo cell activationL Chatenoud, C Ferran, J F Bach
American Journal of Obstetrics and Gynecology|October 28, 1998
Hormone replacement therapy and body size: how much does lifestyle explain?F Parazzini, L Chatenoud, C La Vecchia
Presse Medicale (Paris, France : 1983)|October 19, 1985
[Present and future value of monoclonal antibodies in nephrology]E Rothschild, L Chatenoud, J F Bach
Transplantation Proceedings|September 1, 1982
Immunomodulation of T cells by thymic hormone and monoclonal anti-T cell antibodyJ F Bach, M Dardenne, L Chatenoud
Immunological Reviews|November 28, 2001
Suppressor T cells--they're back and critical for regulation of autoimmunity!L Chatenoud, B Salomon, J A Bluestone
JAMA|July 6, 1994
Fetal loss and caffeine intakeF Parazzini, L Chatenoud, C La Vecchia
Pageof 26

Showing results (41-50 of 259) with videos related to

Sort By:
Pageof 26
Experimental Nephrology|March 1, 1993
In vivo T cell activation properties of anti-T cell monoclonal antibodiesC Ferran, J F Bach, L Chatenoud
Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine|April 1, 1993
[Monoclonal antibodies. Diagnostic and therapeutic use and prospects for the future]C Ferran, J F Bach, L Chatenoud
Kidney International. Supplement|January 1, 1994
Immunological considerations of the uremic and dialyzed patientL Chatenoud, P Jungers, B Descamps-Latscha
Presse Medicale (Paris, France : 1983)|March 24, 1984
[Role of interleukins in autoimmunity]D Fradelizi, A Harel-Bellan, L Chatenoud
Current Topics in Microbiology and Immunology|January 1, 1991
The anti-CD3-induced syndrome: a consequence of massive in vivo cell activationL Chatenoud, C Ferran, J F Bach
American Journal of Obstetrics and Gynecology|October 28, 1998
Hormone replacement therapy and body size: how much does lifestyle explain?F Parazzini, L Chatenoud, C La Vecchia
Presse Medicale (Paris, France : 1983)|October 19, 1985
[Present and future value of monoclonal antibodies in nephrology]E Rothschild, L Chatenoud, J F Bach
Transplantation Proceedings|September 1, 1982
Immunomodulation of T cells by thymic hormone and monoclonal anti-T cell antibodyJ F Bach, M Dardenne, L Chatenoud
Immunological Reviews|November 28, 2001
Suppressor T cells--they're back and critical for regulation of autoimmunity!L Chatenoud, B Salomon, J A Bluestone
JAMA|July 6, 1994
Fetal loss and caffeine intakeF Parazzini, L Chatenoud, C La Vecchia
Pageof 26